Abstract
Human prion diseases are rare fatal neurodegenerative conditions that occur as sporadic, inherited, and acquired disorders. Despite clinico-pathological variations, there are common clinical features and characteristic neuropathological changes accompanied by the accumulation of a disease-associated form of the prion protein in the brain (and, in variant, CJD also in lymphoid tissues). While neuropathological examination of the brain is required for an absolutely definite diagnosis, probable or highly probable clinical diagnosis is possible in the majority of cases.
In this chapter, the clinical assessment of human prion disease is reviewed with emphasis on the role of clinical features and relevant clinical investigations in their diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parchi P, Giese A, Capellari S et al (1999) Classification of sporadic Creutzfeldt–Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46(2):224–233
Brown P, Brandel J-P, Sato T et al (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 18(6):901–907
Liberski PP (2013) Kuru: a journey back in time from Papua New Guinea to the Neanderthals’ extinction. Pathogens 2(3):472–505
Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C et al (1997) Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389(6650):498–501
Hewitt PE, Llewelyn CA, Mackenzie J et al (2006) Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiology Review study. Vox Sang 91(3):221–230
Peden A, McCardle L, Head MW, Love S, Ward HJT, Cousens SN, Keeling DM, Millar CM, Hill FGH, Ironside JW (2010) Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 16(2):296–304
Kovács G, Puopolo M, Ladogana A, Pocchiari M, Budka H et al (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118(2):166–174
Gambetti P, Puoti G, Zou WG (2011) Variably protease-sensitive prionopathy: a novel disease of the prion protein. J Mol Neurosci 45(3):422–424
Head MW, Yull HM, Ritchie DL, Ironside JW et al (2013) Variably protease-sensitive prionopathy in the UK: a retrospective review 1991–2008. Brain 136(4):1102–1115
Gill ON, Spencer Y, Richard-Loendt A et al (2013) Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 347:f5675
Garske T, Ghani AC (2010) Uncertainty in the tail of the variant Creutzfeldt-Jakob disease epidemic in the UK. PLoS One 5(12):e15626
Knight R (2008) Clinical features and diagnosis of human prion diseases. Future Neurol 3(4):473–481
Heath CA, Cooper SA, Murray K, Knight RSG, Will RG et al (2010) Validation of diagnostic criteria for variant CJD. Ann Neurol 67(6):761–770
Rudge P et al (2015) Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Brain 138(11):3386–3399
Will RG, Alpers MP, Dormont D, Schonberger LB (2004) In: Prusiner SB (ed) Infectious and sporadic prion diseases. Prion biology and diseases. Cold Spring Harbor Laboratory Press, New York, pp 629–671
Cooper SA, Murray KL, Heath CA, Will RG, Knight RSG (2006) Sporadic Creutzfeldt–Jakob disease with cerebellar ataxia at onset in the UK. J Neurol Neurosurg Psychiatry 77(11):1273–1275. doi:10.1136/jnnp.2006.088930
Cooper SA, Murray KL, Heath CA, Will RG, Knight RSG (2005) Isolated visual symptoms at onset in sporadic Creutzfeldt-Jakob disease: the clinical phenotype of the “Heidenhain variant”. Br J Ophthalmol 89(10):1341–1342. doi:10.1136/bjo.2005.074856
Parchi P, Strammiello R, Notari S et al (2009) Incidence and spectrum of sporadic Creutzfeldt–Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118(5):659–671. doi:10.1007/s00401-009-0585-1
Spencer MD, Knight RSG, Will RG (2002) First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 324(7352):1479–1482
Collie DA, Sellar RJ, Zeidler M, Colchester A, Knight RSG, Will RG (2001) MRI of Creutzfeldt±Jakob disease: imaging features and recommended MRI protocol. Clin Radiol 56(9):726–739
Collie DA, Summers DM, Sellar RJ et al (2003) Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathlogically confirmed cases. Am J Neuroradiol 24(8):1560–1569
Zerr I, Pocchiari M, Collins S, Brandel J-P, de Pedro Cuesta J, Knight RS et al (2000) Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55(6):811–815
G Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RSG, Green AJE (2010) The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 81(11):1243–1248
McGuire L, Peden AH, Orru CD (2012) Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt–Jakob disease. Ann Neurol 72(2):278–285
Edgeworth JA, Farmer M, Sicilia A (2011) Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 377(9764):487–493
Hill AF, Zeidler M, Ironside J, Collinge J (1997) Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349(9045):99–100
Moda F, Gambetti P, Notari S, Concha-Marambio L, Catania M, Park KW, Maderna E, Suardi S, Haïk S, Brandel JP, Ironside J, Knight R, Tagliavini F, Soto C (2014) Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N Engl J Med 371(6):530–539
Orru C et al (2014) A test for Creutzfeldt-Jakob disease using nasal brushings. New Engl J Med 371(6):519–529. doi:10.1056/NEJMoa1315200
Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers DM et al (2009) MRI lesion profiles in sporadic Creutzfeldt_Jakob disease. Neurology 72(23):1994–2001
Steinhoff BJ, Racker S, Herrendorf G, Poser S, Grosche S et al (1996) Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 53(2):162–166
Yamada M, Variant CJD Working Group (2006) The first Japanese case of variant Creutzfeldt-Jakob disease showing periodic electroencephalogram. Lancet 367(9513):874
Binelli S, Agazzi P, Giaccone G, Will RG, Bugiani O, Franceschetti S, Tagliavin F (2006) Periodic electroencephalogram complexes in a patient with variant Creutzfeldt-Jakob disease. Ann Neurol 59(2):423–427
Sanchez-Juan P, Green A, Ladogana A et al (2006) CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67(4):637–643
Shibuya S, Higuchi J, Shin RW, Tateishi J, Kitamoto T (1998) Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann Neurol 43(6):826–828
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Knight, R. (2017). Clinical Features and Diagnosis of Human Prion Diseases. In: Liberski, P. (eds) Prion Diseases. Neuromethods, vol 129. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7211-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7211-1_4
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7209-8
Online ISBN: 978-1-4939-7211-1
eBook Packages: Springer Protocols